drugset / Trial / NCT02784015

Response Based Treatment for Children With Unresectable Localized Soft Tissue Sarcoma

NCT02784015

Phase 2 Unknown 41 enrolled Samsung Medical Center
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the treatment outcome of unresectable soft tissue sarcoma using response based treatment

Timeline

Start
2016-05
Primary completion
2020-05
Completion
2023-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule
Subject Cisplatin Other / unclassified
Subject Cyclophosphamide Other / unclassified
Subject Doxorubicin Other / unclassified
Subject Etoposide Small molecule
Subject Ifosfamide Small molecule
Subject Melphalan Small molecule
Subject Thiotepa Other / unclassified

Indications